翻訳と辞書 |
Konstance Knox : ウィキペディア英語版 | Konstance Knox
Konstance K. Knox (born October 14, 1955) is an American virologist and entrepreneur who founded Viracor,〔〔〔 the Wisconsin Viral Research Group (WVRG) and Viracor's Institute for Viral Pathogenesis (IVP).〔〔http://www.mult-sclerosis.org/news/Dec2000/HHV6ResearchInMS.html〕 In 2000, Viracor became the first biotechnology company in the United States to correlate multiple sclerosis with human herpesvirus 6 (HHV-6).〔 ==Biography==
Born and raised in Wisconsin, Knox received her bachelor's degree in medical laboratory sciences from Marquette University and was board certified by the American Society for Clinical Pathology in 1977. After receiving a master's degree in business management in 1990, Knox entered the Medical College of Wisconsin's graduate pathology program as a doctoral student in 1992, where she investigated the pathogenetic interactions between HIV and HHV-6 as her doctoral dissertation research project under Donald Carrigan with whom she collaborated on various publications during the period. She received her PhD in 1994.〔(【引用サイトリンク】url=http://www.chubbybrain.com/companies/physiogenix/people/konstance-k-knox#axzz1f8ixg2Jr )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Konstance Knox」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|